<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Amor Lopez A</submitter><funding>Fundación Bancaria Caixa d&amp;apos;Estalvis i Pensions de Barcelona</funding><funding>Fundación Fero</funding><funding>Ministerio de Economía, Industria y Competitividad, Gobierno de España</funding><funding>Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona</funding><funding>Fundación Científica Asociación Española Contra el Cáncer</funding><pagination>7406</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8303474</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(14)</volume><pubmed_abstract>Several studies have demonstrated that melanoma-derived extracellular vesicles (EVs) are involved in lymph node metastasis; however, the molecular mechanisms involved are not completely defined. Here, we found that EMILIN-1 is proteolyzed and secreted in small EVs (sEVs) as a novel mechanism to reduce its intracellular levels favoring metastasis in mouse melanoma lymph node metastatic cells. Interestingly, we observed that EMILIN-1 has intrinsic tumor and metastasis suppressive-like properties reducing effective migration, cell viability, primary tumor growth, and metastasis. Overall, our analysis suggests that the inactivation of EMILIN-1 by proteolysis and secretion in sEVs reduce its intrinsic tumor suppressive activities in melanoma favoring tumor progression and metastasis.</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Inactivation of EMILIN-1 by Proteolysis and Secretion in Small Extracellular Vesicles Favors Melanoma Progression and Metastasis.</pubmed_title><pmcid>PMC8303474</pmcid><funding_grant_id>N/A</funding_grant_id><funding_grant_id>SAF2014-54541-R</funding_grant_id><pubmed_authors>Recio JA</pubmed_authors><pubmed_authors>Al-Shahrour F</pubmed_authors><pubmed_authors>Spessotto P</pubmed_authors><pubmed_authors>Mazariegos MS</pubmed_authors><pubmed_authors>Capuano A</pubmed_authors><pubmed_authors>Ximenez-Embun P</pubmed_authors><pubmed_authors>Munoz J</pubmed_authors><pubmed_authors>Hergueta-Redondo M</pubmed_authors><pubmed_authors>Doliana R</pubmed_authors><pubmed_authors>Megias D</pubmed_authors><pubmed_authors>Peinado H</pubmed_authors><pubmed_authors>Amor Lopez A</pubmed_authors><pubmed_authors>Munoz E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inactivation of EMILIN-1 by Proteolysis and Secretion in Small Extracellular Vesicles Favors Melanoma Progression and Metastasis.</name><description>Several studies have demonstrated that melanoma-derived extracellular vesicles (EVs) are involved in lymph node metastasis; however, the molecular mechanisms involved are not completely defined. Here, we found that EMILIN-1 is proteolyzed and secreted in small EVs (sEVs) as a novel mechanism to reduce its intracellular levels favoring metastasis in mouse melanoma lymph node metastatic cells. Interestingly, we observed that EMILIN-1 has intrinsic tumor and metastasis suppressive-like properties reducing effective migration, cell viability, primary tumor growth, and metastasis. Overall, our analysis suggests that the inactivation of EMILIN-1 by proteolysis and secretion in sEVs reduce its intrinsic tumor suppressive activities in melanoma favoring tumor progression and metastasis.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jul</publication><modification>2026-05-01T03:06:47.106Z</modification><creation>2022-02-11T00:11:07.979Z</creation></dates><accession>S-EPMC8303474</accession><cross_references><pubmed>34299025</pubmed><doi>10.3390/ijms22147406</doi></cross_references></HashMap>